SCHEMBL20133581

SCHEMBL20133581

Cc1cc(C)c(C(=O)N2CCN(c3cccnc3C)CC2)c(C)c1NC1CCN(c2ncccc2Cl)CC1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.62
RPTOR Q8N122 5/20 0.62
MLST8 Q9BVC4 5/20 0.62
MALT1 Q9UDY8 4/20 0.47
AVPR1A P37288 1/20 0.41
TRPA1 O75762 1/20 0.41
KCNH2 Q12809 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133576 0.91 MTOR (0.75) MTORRPTORMLST8MALT1AVPR1A
SCHEMBL21340096 0.90 MTOR (0.65) MTORRPTORMLST8MALT1AVPR1A
SCHEMBL20141044 0.90 MTOR (0.65) MTORRPTORMLST8MALT1AVPR1A
SCHEMBL20133684 0.90 MTOR (0.65) MTORRPTORMLST8MALT1AVPR1A
SCHEMBL20133849 0.90 MTOR (0.57) MTORRPTORMLST8MALT1AVPR1A
SCHEMBL20133783 0.88 MTOR (0.60) MTORRPTORMLST8MALT1TRPA1
SCHEMBL20149904 0.87 MTOR (0.52) MTORRPTORMLST8MALT1
SCHEMBL20149906 0.87 MTOR (0.54) MTORRPTORMLST8MALT1TRPA1
SCHEMBL20133577 0.85 MALT1 (0.53) MTORRPTORMLST8MALT1TRPV1
SCHEMBL22693192 0.84 MTOR (0.63) MTORRPTORMLST8MALT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.